speb/financial-data huggingface dataset:
BCAL cash_flow (annual, 2023-12-31) — Operating Cash Flow: 33102000.00
BCAL cash_flow (annual, 2023-12-31) — Operating Gains Losses: 143000.00
BCAL income_statement (annual, 2023-12-31) — Operating Revenue: 97517000.00
BCAL balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 18369115.00
BCAL balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -4459000.00
BCAL balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 1195000.00
BCAL cash_flow (annual, 2023-12-31) — Other Non Cash Items: 2647000.00
BCAL income_statement (annual, 2023-12-31) — Other Non Interest Expense: 9817000.00
BCAL balance_sheet (annual, 2023-12-31) — Other Properties: 9291000.00
BCAL balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 130035000.00
BCAL balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
BCAL income_statement (annual, 2023-12-31) — Pretax Income: 36856000.00
BCAL cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 127000.00
BCAL income_statement (annual, 2023-12-31) — Professional Expense And Contract Services Expense: 3211000.00
BCAL cash_flow (annual, 2023-12-31) — Purchase Of Investment: -67690000.00
BCAL cash_flow (annual, 2023-12-31) — Purchase Of PPE: -302000.00
BCAL income_statement (annual, 2023-12-31) — Reconciled Depreciation: 1919000.00
BCAL cash_flow (annual, 2023-12-31) — Repayment Of Debt: -57000000.00
BCAL cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -889000.00
BCAL income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: 0.00
BCAL balance_sheet (annual, 2023-12-31) — Retained Earnings: 70575000.00
BCAL income_statement (annual, 2023-12-31) — Salaries And Wages: 40098000.00
BCAL cash_flow (annual, 2023-12-31) — Sale Of Business: 0.00
BCAL cash_flow (annual, 2023-12-31) — Sale Of Investment: 48349000.00
BCAL cash_flow (annual, 2023-12-31) — Sale Of PPE: 0.00
BCAL income_statement (annual, 2023-12-31) — Selling General And Administration: 40098000.00
BCAL balance_sheet (annual, 2023-12-31) — Share Issued: 18369115.00
BCAL income_statement (annual, 2023-12-31) — Special Income Charges: 0.00
BCAL cash_flow (annual, 2023-12-31) — Stock Based Compensation: 4518000.00
BCAL balance_sheet (annual, 2023-12-31) — Stockholders Equity: 288152000.00
BCAL balance_sheet (annual, 2023-12-31) — Tangible Book Value: 249154000.00
BCAL income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
BCAL income_statement (annual, 2023-12-31) — Tax Provision: 10946000.00
BCAL income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.30
BCAL balance_sheet (annual, 2023-12-31) — Total Assets: 2360252000.00
BCAL balance_sheet (annual, 2023-12-31) — Total Capitalization: 391017000.00
BCAL balance_sheet (annual, 2023-12-31) — Total Debt: 114982000.00
BCAL balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 288152000.00
BCAL balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 2072100000.00
BCAL income_statement (annual, 2023-12-31) — Total Unusual Items: 0.00
BCAL income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 0.00
BCAL balance_sheet (quarterly, 2024-09-30) — Cash Financial: 115165000.00
BCAL cash_flow (quarterly, 2024-09-30) — Gain Loss On Investment Securities: 0.00
BCAL income_statement (quarterly, 2024-09-30) — Gain On Sale Of Security: 0.00
BCAL cash_flow (quarterly, 2024-09-30) — Issuance Of Debt: 0.00
BCAL cash_flow (quarterly, 2024-09-30) — Long Term Debt Issuance: 0.00
BCAL income_statement (annual, 2024-12-31) — +Total Revenue: 127763000.00
BCAL balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -8682000.00
BCAL balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -8682000.00
BCAL income_statement (annual, 2024-12-31) — Amortization: 1877000.00
BCAL cash_flow (annual, 2024-12-31) — Amortization Cash Flow: 1877000.00
BCAL cash_flow (annual, 2024-12-31) — Amortization Of Intangibles: 1877000.00
BCAL income_statement (annual, 2024-12-31) — Amortization Of Intangibles Income Statement: 1877000.00
BCAL cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 692000.00
BCAL cash_flow (quarterly, 2024-12-31) — Asset Impairment Charge: 78000.00
BCAL income_statement (annual, 2024-12-31) — Basic Average Shares: 24695455.00
BCAL income_statement (annual, 2024-12-31) — Basic EPS: 0.22
BCAL cash_flow (annual, 2024-12-31) — Beginning Cash Position: 86793000.00
BCAL balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 4766000.00
BCAL balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 4766000.00
BCAL cash_flow (annual, 2024-12-31) — Capital Expenditure: -552000.00
BCAL balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 18310000.00
BCAL balance_sheet (annual, 2024-12-31) — Capital Stock: 442469000.00
BCAL balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 60471000.00
BCAL balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Federal Funds Sold: 418991000.00
BCAL cash_flow (annual, 2024-12-31) — Cash Dividends Paid: 0.00
BCAL balance_sheet (annual, 2024-12-31) — Cash Financial: 60471000.00
BCAL balance_sheet (quarterly, 2024-12-31) — Cash Financial: 60471000.00
BCAL cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -273578000.00
BCAL cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: 524655000.00
BCAL cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 50292000.00
BCAL cash_flow (annual, 2024-12-31) — Change In Other Working Capital: 22087000.00
BCAL cash_flow (annual, 2024-12-31) — Change In Working Capital: 22087000.00
BCAL cash_flow (annual, 2024-12-31) — Changes In Cash: 301369000.00
BCAL balance_sheet (annual, 2024-12-31) — Common Stock: 442469000.00
BCAL cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: 0.00
BCAL balance_sheet (annual, 2024-12-31) — Common Stock Equity: 511836000.00
BCAL cash_flow (annual, 2024-12-31) — Common Stock Payments: -1966000.00
BCAL cash_flow (annual, 2024-12-31) — Deferred Income Tax: -426000.00
BCAL cash_flow (annual, 2024-12-31) — Deferred Tax: -426000.00
BCAL cash_flow (annual, 2024-12-31) — Depreciation: 1759000.00
BCAL cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 3636000.00
BCAL income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 1877000.00
BCAL cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 3636000.00
BCAL income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 1877000.00
BCAL income_statement (annual, 2024-12-31) — Diluted Average Shares: 24695455.00
BCAL income_statement (annual, 2024-12-31) — Diluted EPS: 0.22
BCAL income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 5433000.00
BCAL cash_flow (annual, 2024-12-31) — End Cash Position: 388162000.00
BCAL cash_flow (annual, 2024-12-31) — Financing Cash Flow: -273578000.00
BCAL cash_flow (annual, 2024-12-31) — Free Cash Flow: 49740000.00
BCAL cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 0.00
BCAL cash_flow (quarterly, 2024-12-31) — Gain Loss On Investment Securities: 0.00
BCAL cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: 19000.00
BCAL cash_flow (quarterly, 2024-12-31) — Gain Loss On Sale Of PPE: 0.00
BCAL income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 0.00
BCAL income_statement (quarterly, 2024-12-31) — Gain On Sale Of Security: 0.00
BCAL balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -6641000.00
BCAL income_statement (annual, 2024-12-31) — General And Administrative Expense: 51255000.00
BCAL balance_sheet (annual, 2024-12-31) — Goodwill: 111787000.00
BCAL balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 134058000.00
BCAL balance_sheet (annual, 2024-12-31) — Gross PPE: 36627000.00
BCAL balance_sheet (annual, 2024-12-31) — Held To Maturity Securities: 53280000.00
BCAL cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 2886000.00
BCAL cash_flow (quarterly, 2024-12-31) — Income Tax Paid Supplemental Data: 0.00
BCAL income_statement (annual, 2024-12-31) — Interest Expense: 56814000.00
BCAL income_statement (annual, 2024-12-31) — Interest Income: 179798000.00
BCAL cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 52093000.00
BCAL cash_flow (quarterly, 2024-12-31) — Interest Paid Supplemental Data: 18158000.00
BCAL balance_sheet (annual, 2024-12-31) — Invested Capital: 581561000.00
BCAL cash_flow (annual, 2024-12-31) — Investing Cash Flow: 524655000.00
BCAL balance_sheet (annual, 2024-12-31) — Investments And Advances: 195281000.00
BCAL cash_flow (annual, 2024-12-31) — Issuance Of Debt: 0.00
BCAL cash_flow (quarterly, 2024-12-31) — Issuance Of Debt: 0.00
BCAL balance_sheet (annual, 2024-12-31) — Land And Improvements: 5386000.00
BCAL balance_sheet (quarterly, 2024-12-31) — Land And Improvements: 5386000.00
BCAL balance_sheet (annual, 2024-12-31) — Leases: 5976000.00
BCAL balance_sheet (quarterly, 2024-12-31) — Leases: 5976000.00
BCAL balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 18310000.00
BCAL balance_sheet (annual, 2024-12-31) — Long Term Debt: 69725000.00
BCAL balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 88035000.00
BCAL cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 0.00
BCAL cash_flow (quarterly, 2024-12-31) — Long Term Debt Issuance: 0.00
BCAL cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -85000000.00
BCAL balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 6149000.00
BCAL balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 6149000.00
BCAL cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 336298000.00
BCAL cash_flow (quarterly, 2024-12-31) — Net Business Purchase And Sale: 0.00
BCAL cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -1966000.00
BCAL balance_sheet (annual, 2024-12-31) — Net Debt: 9254000.00
BCAL balance_sheet (quarterly, 2024-12-31) — Net Debt: 9254000.00
BCAL income_statement (annual, 2024-12-31) — Net Income: 5433000.00
BCAL income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 5433000.00
BCAL income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 5433000.00
BCAL income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 5433000.00
BCAL income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 5433000.00
BCAL cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 5433000.00
BCAL income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 5433000.00
BCAL income_statement (annual, 2024-12-31) — Net Interest Income: 122984000.00
BCAL cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 31104000.00
BCAL cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -85000000.00
BCAL cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -85000000.00
BCAL cash_flow (annual, 2024-12-31) — Net Other Investing Changes: -587000.00
BCAL balance_sheet (annual, 2024-12-31) — Net PPE: 27945000.00
BCAL cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -552000.00
BCAL balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 377778000.00
BCAL income_statement (annual, 2024-12-31) — Normalized Income: 16163006.00
BCAL income_statement (annual, 2024-12-31) — Occupancy And Equipment: 7242000.00
BCAL cash_flow (annual, 2024-12-31) — Operating Cash Flow: 50292000.00
BCAL cash_flow (annual, 2024-12-31) — Operating Gains Losses: 699000.00
BCAL cash_flow (quarterly, 2024-12-31) — Operating Gains Losses: 1095000.00
BCAL income_statement (annual, 2024-12-31) — Operating Revenue: 127763000.00
BCAL balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 32265935.00
BCAL balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -6641000.00
BCAL balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 22271000.00
BCAL cash_flow (annual, 2024-12-31) — Other Non Cash Items: 3489000.00
BCAL income_statement (annual, 2024-12-31) — Other Non Interest Expense: 18570000.00
BCAL balance_sheet (annual, 2024-12-31) — Other Properties: 14350000.00
BCAL balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 142001000.00
BCAL income_statement (annual, 2024-12-31) — Other Special Charges: 19000.00
BCAL income_statement (quarterly, 2024-12-31) — Other Special Charges: 0.00
BCAL balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
BCAL income_statement (annual, 2024-12-31) — Pretax Income: 8263000.00
BCAL cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 950000.00
BCAL income_statement (annual, 2024-12-31) — Professional Expense And Contract Services Expense: 2559000.00
BCAL cash_flow (annual, 2024-12-31) — Purchase Of Investment: -2041000.00
BCAL cash_flow (annual, 2024-12-31) — Purchase Of PPE: -552000.00
BCAL income_statement (annual, 2024-12-31) — Reconciled Depreciation: 3636000.00
BCAL cash_flow (annual, 2024-12-31) — Repayment Of Debt: -85000000.00
BCAL cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -1966000.00
BCAL income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 16288000.00
BCAL income_statement (quarterly, 2024-12-31) — Restructuring And Mergern Acquisition: 643000.00
BCAL balance_sheet (annual, 2024-12-31) — Retained Earnings: 76008000.00
BCAL income_statement (annual, 2024-12-31) — Salaries And Wages: 51255000.00
BCAL cash_flow (annual, 2024-12-31) — Sale Of Business: 336298000.00
BCAL cash_flow (quarterly, 2024-12-31) — Sale Of Business: 0.00
BCAL cash_flow (annual, 2024-12-31) — Sale Of Investment: 33145000.00
BCAL income_statement (annual, 2024-12-31) — Selling General And Administration: 51255000.00
BCAL balance_sheet (annual, 2024-12-31) — Share Issued: 32265935.00
BCAL income_statement (annual, 2024-12-31) — Special Income Charges: -16307000.00
BCAL cash_flow (annual, 2024-12-31) — Stock Based Compensation: 6244000.00
BCAL balance_sheet (annual, 2024-12-31) — Stockholders Equity: 511836000.00
BCAL balance_sheet (annual, 2024-12-31) — Tangible Book Value: 377778000.00
BCAL income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -5576994.00
BCAL income_statement (annual, 2024-12-31) — Tax Provision: 2830000.00
BCAL income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.34
BCAL balance_sheet (annual, 2024-12-31) — Total Assets: 4031654000.00
BCAL balance_sheet (annual, 2024-12-31) — Total Capitalization: 581561000.00
BCAL balance_sheet (annual, 2024-12-31) — Total Debt: 88035000.00
BCAL balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 511836000.00
BCAL balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 3519818000.00
BCAL income_statement (annual, 2024-12-31) — Total Unusual Items: -16307000.00
BCAL income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -16307000.00
BCAL income_statement (quarterly, 2025-03-31) — +Total Revenue: 44821000.00
BCAL income_statement (quarterly, 2025-03-31) — Amortization: 948000.00
BCAL cash_flow (quarterly, 2025-03-31) — Amortization Cash Flow: 948000.00
BCAL cash_flow (quarterly, 2025-03-31) — Amortization Of Intangibles: 948000.00
BCAL income_statement (quarterly, 2025-03-31) — Amortization Of Intangibles Income Statement: 948000.00
BCAL balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 122948000.00
BCAL income_statement (quarterly, 2025-03-31) — Basic Average Shares: 32409615.00
BCAL income_statement (quarterly, 2025-03-31) — Basic EPS: 0.52
BCAL cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 388162000.00
BCAL cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -105000.00
BCAL balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 17142000.00
BCAL balance_sheet (quarterly, 2025-03-31) — Capital Stock: 442934000.00
BCAL balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 80441000.00
BCAL balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Federal Funds Sold: 454781000.00
BCAL cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: 0.00
BCAL cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -57239000.00
BCAL cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 101335000.00
BCAL cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 6983000.00
BCAL cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -7870000.00
BCAL cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -7870000.00
BCAL cash_flow (quarterly, 2025-03-31) — Changes In Cash: 51079000.00
BCAL balance_sheet (quarterly, 2025-03-31) — Common Stock: 442934000.00
BCAL cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: 0.00
BCAL balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 531384000.00
BCAL cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -1055000.00
BCAL cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 5566000.00
BCAL cash_flow (quarterly, 2025-03-31) — Deferred Tax: 5566000.00
BCAL cash_flow (quarterly, 2025-03-31) — Depreciation: 546000.00
BCAL cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 1494000.00
BCAL income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 948000.00
BCAL cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 1494000.00
BCAL income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 948000.00
BCAL income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 32698227.00
BCAL income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.52
BCAL income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 16853000.00
BCAL cash_flow (quarterly, 2025-03-31) — End Cash Position: 439241000.00
BCAL cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -57239000.00
BCAL cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 6878000.00
BCAL cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of PPE: 1000.00
BCAL balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -4411000.00
BCAL income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 16268000.00
BCAL balance_sheet (quarterly, 2025-03-31) — Goodwill: 111780000.00
BCAL balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 133103000.00
BCAL balance_sheet (quarterly, 2025-03-31) — Gross PPE: 26538000.00
BCAL balance_sheet (quarterly, 2025-03-31) — Held To Maturity Securities: 53194000.00
BCAL cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 0.00
BCAL income_statement (quarterly, 2025-03-31) — Interest Expense: 14570000.00
BCAL income_statement (quarterly, 2025-03-31) — Interest Income: 56825000.00
BCAL cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 16965000.00
BCAL balance_sheet (quarterly, 2025-03-31) — Invested Capital: 601692000.00
BCAL cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 101335000.00
BCAL balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 184787000.00
BCAL cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 0.00
BCAL balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 17142000.00
BCAL balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 70308000.00
BCAL balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 87450000.00
BCAL cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 0.00
BCAL cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: 0.00
BCAL cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -1055000.00
BCAL income_statement (quarterly, 2025-03-31) — Net Income: 16853000.00
BCAL income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 16853000.00
BCAL income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 16853000.00
BCAL income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 16853000.00
BCAL income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 16853000.00
BCAL cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 16853000.00
BCAL income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 16853000.00
BCAL income_statement (quarterly, 2025-03-31) — Net Interest Income: 42255000.00
BCAL cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 14136000.00
BCAL cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 0.00
BCAL cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 0.00
BCAL cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: -17000.00
BCAL balance_sheet (quarterly, 2025-03-31) — Net PPE: 26538000.00
BCAL cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -105000.00
BCAL balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 398281000.00
BCAL income_statement (quarterly, 2025-03-31) — Normalized Income: 16853000.00
BCAL income_statement (quarterly, 2025-03-31) — Occupancy And Equipment: 2152000.00
BCAL cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 6983000.00
BCAL cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -577000.00
BCAL income_statement (quarterly, 2025-03-31) — Operating Revenue: 44821000.00
BCAL balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 32402140.00
BCAL balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -4411000.00
BCAL balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 21323000.00
BCAL cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 151000.00
BCAL income_statement (quarterly, 2025-03-31) — Other Non Interest Expense: 4693000.00
BCAL balance_sheet (quarterly, 2025-03-31) — Other Properties: 26538000.00
BCAL balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 8645000.00
BCAL income_statement (quarterly, 2025-03-31) — Other Special Charges: 1000.00
BCAL balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
BCAL income_statement (quarterly, 2025-03-31) — Pretax Income: 23677000.00
BCAL cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 40000.00
BCAL income_statement (quarterly, 2025-03-31) — Professional Expense And Contract Services Expense: 859000.00
BCAL cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: 0.00
BCAL cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -105000.00
BCAL income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 1494000.00
BCAL cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: 0.00
BCAL cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -1055000.00
BCAL income_statement (quarterly, 2025-03-31) — Restructuring And Mergern Acquisition: 0.00
BCAL balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 92861000.00
BCAL income_statement (quarterly, 2025-03-31) — Salaries And Wages: 16268000.00
BCAL cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 14136000.00
BCAL income_statement (quarterly, 2025-03-31) — Selling General And Administration: 16268000.00
BCAL balance_sheet (quarterly, 2025-03-31) — Share Issued: 32402140.00
BCAL income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
BCAL cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 1480000.00
BCAL balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 531384000.00
BCAL balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 398281000.00
BCAL income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
BCAL income_statement (quarterly, 2025-03-31) — Tax Provision: 6824000.00
BCAL income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.29
BCAL balance_sheet (quarterly, 2025-03-31) — Total Assets: 3983090000.00
BCAL balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 601692000.00
BCAL balance_sheet (quarterly, 2025-03-31) — Total Debt: 87450000.00
BCAL balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 531384000.00
BCAL balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 3451706000.00
BCAL income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
BCAL income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
BCAL income_statement (quarterly, 2025-06-30) — +Total Revenue: 44273000.00
BCAL income_statement (quarterly, 2025-06-30) — Amortization: 948000.00
BCAL cash_flow (quarterly, 2025-06-30) — Amortization Cash Flow: 948000.00
BCAL cash_flow (quarterly, 2025-06-30) — Amortization Of Intangibles: 948000.00
BCAL income_statement (quarterly, 2025-06-30) — Amortization Of Intangibles Income Statement: 948000.00
BCAL balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 185538000.00
BCAL income_statement (quarterly, 2025-06-30) — Basic Average Shares: 32788372.00
BCAL income_statement (quarterly, 2025-06-30) — Basic EPS: 0.43
BCAL cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 439241000.00
BCAL cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -34000.00
BCAL balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 16715000.00
BCAL balance_sheet (quarterly, 2025-06-30) — Capital Stock: 444365000.00
BCAL balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 84017000.00
BCAL balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Federal Funds Sold: 445690000.00
BCAL cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -48314000.00
BCAL cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 25788000.00
BCAL cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 13422000.00
BCAL cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -800000.00
BCAL cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -800000.00
BCAL cash_flow (quarterly, 2025-06-30) — Changes In Cash: -9104000.00
BCAL balance_sheet (quarterly, 2025-06-30) — Common Stock: 444365000.00
BCAL balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 547593000.00
BCAL cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -155000.00
BCAL cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 2386000.00
BCAL cash_flow (quarterly, 2025-06-30) — Deferred Tax: 2386000.00
BCAL cash_flow (quarterly, 2025-06-30) — Depreciation: 460000.00
BCAL cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 1408000.00
BCAL income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 948000.00
BCAL cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 1408000.00
BCAL income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 948000.00
BCAL income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 32788372.00
BCAL income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.43
BCAL income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 14099000.00
BCAL cash_flow (quarterly, 2025-06-30) — End Cash Position: 430137000.00
BCAL cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -48314000.00
BCAL cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 13388000.00
BCAL cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of PPE: 0.00
BCAL balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -3732000.00
BCAL income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 15688000.00
BCAL balance_sheet (quarterly, 2025-06-30) — Goodwill: 110934000.00
BCAL balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 131309000.00
BCAL balance_sheet (quarterly, 2025-06-30) — Gross PPE: 25823000.00
BCAL balance_sheet (quarterly, 2025-06-30) — Held To Maturity Securities: 53108000.00
BCAL cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 9177000.00
BCAL income_statement (quarterly, 2025-06-30) — Interest Expense: 14369000.00
BCAL income_statement (quarterly, 2025-06-30) — Interest Income: 55786000.00
BCAL cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 14093000.00
BCAL balance_sheet (quarterly, 2025-06-30) — Invested Capital: 600476000.00
BCAL cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 25788000.00
BCAL balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 241275000.00
BCAL balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 16715000.00
BCAL balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 52883000.00
BCAL balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 69598000.00
BCAL cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -18000000.00
BCAL cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -155000.00
BCAL income_statement (quarterly, 2025-06-30) — Net Income: 14099000.00
BCAL income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 14099000.00
BCAL income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 14099000.00
BCAL income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 14099000.00
BCAL income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 14099000.00
BCAL cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 14099000.00
BCAL income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 14099000.00
BCAL income_statement (quarterly, 2025-06-30) — Net Interest Income: 41417000.00
BCAL cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -56271000.00
BCAL cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -18000000.00
BCAL cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -18000000.00
BCAL cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: 3010000.00
BCAL balance_sheet (quarterly, 2025-06-30) — Net PPE: 25823000.00
BCAL cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -34000.00
BCAL balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 416284000.00
BCAL income_statement (quarterly, 2025-06-30) — Normalized Income: 14099000.00
BCAL income_statement (quarterly, 2025-06-30) — Occupancy And Equipment: 2094000.00
BCAL cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 13422000.00
BCAL cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 1000.00
BCAL income_statement (quarterly, 2025-06-30) — Operating Revenue: 44273000.00
BCAL balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 32463311.00
BCAL balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -3732000.00
BCAL balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 20375000.00
BCAL cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 1325000.00
BCAL income_statement (quarterly, 2025-06-30) — Other Non Interest Expense: 5131000.00
BCAL balance_sheet (quarterly, 2025-06-30) — Other Properties: 25823000.00
BCAL balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 2629000.00
BCAL balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
BCAL income_statement (quarterly, 2025-06-30) — Pretax Income: 20074000.00
BCAL cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 61000.00
BCAL income_statement (quarterly, 2025-06-30) — Professional Expense And Contract Services Expense: 972000.00
BCAL cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -66514000.00
BCAL cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -34000.00
BCAL income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 1408000.00
BCAL cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -18000000.00
BCAL cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -155000.00
BCAL income_statement (quarterly, 2025-06-30) — Restructuring And Mergern Acquisition: 0.00
BCAL balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 106960000.00
BCAL income_statement (quarterly, 2025-06-30) — Salaries And Wages: 15688000.00
BCAL cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 10243000.00
BCAL income_statement (quarterly, 2025-06-30) — Selling General And Administration: 15688000.00
BCAL balance_sheet (quarterly, 2025-06-30) — Share Issued: 32463311.00
BCAL income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
BCAL cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 1525000.00
BCAL balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 547593000.00
BCAL balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 416284000.00
BCAL income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
BCAL income_statement (quarterly, 2025-06-30) — Tax Provision: 5975000.00
BCAL income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.30
BCAL balance_sheet (quarterly, 2025-06-30) — Total Assets: 3953717000.00
BCAL balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 600476000.00
BCAL balance_sheet (quarterly, 2025-06-30) — Total Debt: 69598000.00
BCAL balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 547593000.00
BCAL balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 3406124000.00
BCAL income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
BCAL income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
BCAL income_statement (quarterly, 2025-09-30) — +Total Revenue: 45183000.00
BCAL income_statement (quarterly, 2025-09-30) — Amortization: 948000.00
BCAL cash_flow (quarterly, 2025-09-30) — Amortization Cash Flow: 948000.00
BCAL cash_flow (quarterly, 2025-09-30) — Amortization Of Intangibles: 948000.00
BCAL income_statement (quarterly, 2025-09-30) — Amortization Of Intangibles Income Statement: 948000.00
BCAL balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 209402000.00
BCAL income_statement (quarterly, 2025-09-30) — Basic Average Shares: 32675000.00
BCAL income_statement (quarterly, 2025-09-30) — Basic EPS: 0.48
BCAL cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 430137000.00
BCAL cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -108000.00
BCAL balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 19154000.00
BCAL balance_sheet (quarterly, 2025-09-30) — Capital Stock: 444132000.00
BCAL balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 95046000.00
BCAL balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Federal Funds Sold: 574810000.00
BCAL cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 125689000.00
BCAL cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -12587000.00
BCAL cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 15977000.00
BCAL cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 2273000.00
BCAL cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 2273000.00
BCAL cash_flow (quarterly, 2025-09-30) — Changes In Cash: 129079000.00
BCAL balance_sheet (quarterly, 2025-09-30) — Common Stock: 444132000.00
BCAL balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 564724000.00
BCAL cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -1725000.00
BCAL cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 819000.00
BCAL cash_flow (quarterly, 2025-09-30) — Deferred Tax: 819000.00
BCAL cash_flow (quarterly, 2025-09-30) — Depreciation: 416000.00
BCAL cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 1364000.00
BCAL income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 948000.00
BCAL cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 1364000.00
BCAL income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 948000.00
BCAL income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 32811827.00
BCAL income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.48
BCAL income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 15684000.00
BCAL cash_flow (quarterly, 2025-09-30) — End Cash Position: 559216000.00
BCAL cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 125689000.00
BCAL cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 15869000.00
BCAL cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of PPE: 0.00
BCAL balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -2052000.00
BCAL income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 15070000.00
BCAL balance_sheet (quarterly, 2025-09-30) — Goodwill: 110934000.00
BCAL balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 130361000.00
BCAL balance_sheet (quarterly, 2025-09-30) — Gross PPE: 27665000.00
BCAL balance_sheet (quarterly, 2025-09-30) — Held To Maturity Securities: 53022000.00
BCAL cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 2015000.00
BCAL income_statement (quarterly, 2025-09-30) — Interest Expense: 14673000.00
BCAL income_statement (quarterly, 2025-09-30) — Interest Income: 57188000.00
BCAL cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 14656000.00
BCAL balance_sheet (quarterly, 2025-09-30) — Invested Capital: 598167000.00
BCAL cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -12587000.00
BCAL balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 262424000.00
BCAL balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 19154000.00
BCAL balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 33443000.00
BCAL balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 52597000.00
BCAL cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -20000000.00
BCAL cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -1725000.00
BCAL income_statement (quarterly, 2025-09-30) — Net Income: 15684000.00
BCAL income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 15684000.00
BCAL income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 15684000.00
BCAL income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 15684000.00
BCAL income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 15684000.00
BCAL cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 15684000.00
BCAL income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 15684000.00
BCAL income_statement (quarterly, 2025-09-30) — Net Interest Income: 42515000.00
BCAL cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -18260000.00
BCAL cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -20000000.00
BCAL cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -20000000.00
BCAL cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: 0.00
BCAL balance_sheet (quarterly, 2025-09-30) — Net PPE: 27665000.00
BCAL cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -108000.00
BCAL balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 434363000.00
BCAL income_statement (quarterly, 2025-09-30) — Normalized Income: 15684000.00
BCAL income_statement (quarterly, 2025-09-30) — Occupancy And Equipment: 2060000.00
BCAL cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 15977000.00
BCAL cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 0.00
BCAL income_statement (quarterly, 2025-09-30) — Operating Revenue: 45183000.00
BCAL balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 32443056.00
BCAL balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -2052000.00
BCAL balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 19427000.00
BCAL cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 0.00
BCAL income_statement (quarterly, 2025-09-30) — Other Non Interest Expense: 4461000.00
BCAL balance_sheet (quarterly, 2025-09-30) — Other Properties: 27665000.00
BCAL balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 0.00
BCAL balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
BCAL income_statement (quarterly, 2025-09-30) — Pretax Income: 21816000.00
BCAL cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 31000.00
BCAL income_statement (quarterly, 2025-09-30) — Professional Expense And Contract Services Expense: 843000.00
BCAL cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -25530000.00
BCAL cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -108000.00
BCAL income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 1364000.00
BCAL cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -20000000.00
BCAL cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -1725000.00
BCAL income_statement (quarterly, 2025-09-30) — Restructuring And Mergern Acquisition: 0.00
BCAL balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 122644000.00
BCAL income_statement (quarterly, 2025-09-30) — Salaries And Wages: 15070000.00
BCAL cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 7270000.00
BCAL income_statement (quarterly, 2025-09-30) — Selling General And Administration: 15070000.00
BCAL balance_sheet (quarterly, 2025-09-30) — Share Issued: 32443056.00
BCAL income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
BCAL cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 1461000.00
BCAL balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 564724000.00
BCAL balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 434363000.00
BCAL income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
BCAL income_statement (quarterly, 2025-09-30) — Tax Provision: 6132000.00
BCAL income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.28
BCAL balance_sheet (quarterly, 2025-09-30) — Total Assets: 4101209000.00
BCAL balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 598167000.00
BCAL balance_sheet (quarterly, 2025-09-30) — Total Debt: 52597000.00
BCAL balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 564724000.00
BCAL balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 3536485000.00
BCAL income_statement (quarterly, 2025-09-30) — Total Unusual Items: 0.00
BCAL income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 0.00
BCAL income_statement (annual, 2025-12-31) — +Total Revenue: 180178000.00
BCAL income_statement (quarterly, 2025-12-31) — +Total Revenue: 45900000.00
BCAL balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -10411000.00
BCAL balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -10411000.00
BCAL income_statement (annual, 2025-12-31) — Amortization: 3791000.00
BCAL income_statement (quarterly, 2025-12-31) — Amortization: 947000.00
BCAL cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 3791000.00
BCAL cash_flow (quarterly, 2025-12-31) — Amortization Cash Flow: 947000.00
BCAL cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 3791000.00
BCAL cash_flow (quarterly, 2025-12-31) — Amortization Of Intangibles: 947000.00
BCAL income_statement (annual, 2025-12-31) — Amortization Of Intangibles Income Statement: 3791000.00
BCAL income_statement (quarterly, 2025-12-31) — Amortization Of Intangibles Income Statement: 947000.00
BCAL cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 0.00
BCAL cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 0.00
BCAL balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 234867000.00
BCAL balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 234867000.00
BCAL income_statement (annual, 2025-12-31) — Basic Average Shares: 32337436.00
BCAL income_statement (quarterly, 2025-12-31) — Basic Average Shares: 32200000.00
BCAL income_statement (annual, 2025-12-31) — Basic EPS: 1.95
BCAL income_statement (quarterly, 2025-12-31) — Basic EPS: 0.51
BCAL cash_flow (annual, 2025-12-31) — Beginning Cash Position: 388162000.00
BCAL cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 559216000.00
BCAL balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 4766000.00
BCAL balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 4766000.00
BCAL cash_flow (annual, 2025-12-31) — Capital Expenditure: -346000.00
BCAL cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -99000.00
BCAL balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 18936000.00
BCAL balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 18936000.00
BCAL balance_sheet (annual, 2025-12-31) — Capital Stock: 442394000.00
BCAL balance_sheet (quarterly, 2025-12-31) — Capital Stock: 442394000.00
BCAL balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 52013000.00
BCAL balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 52013000.00
BCAL balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Federal Funds Sold: 430845000.00
BCAL balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Federal Funds Sold: 430845000.00
BCAL cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -3253000.00
BCAL cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -75292000.00
BCAL cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -95428000.00
BCAL cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 29753000.00
BCAL cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -84783000.00
BCAL cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 57290000.00
BCAL cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 20908000.00
BCAL cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 4295000.00
BCAL cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 10692000.00
BCAL cash_flow (annual, 2025-12-31) — Change In Working Capital: 4295000.00
BCAL cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 10692000.00
BCAL cash_flow (annual, 2025-12-31) — Changes In Cash: 11751000.00
BCAL cash_flow (quarterly, 2025-12-31) — Changes In Cash: -159303000.00
BCAL balance_sheet (annual, 2025-12-31) — Common Stock: 442394000.00
BCAL balance_sheet (quarterly, 2025-12-31) — Common Stock: 442394000.00
BCAL cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -3253000.00
BCAL balance_sheet (annual, 2025-12-31) — Common Stock Equity: 576586000.00
BCAL balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 576586000.00
BCAL cash_flow (annual, 2025-12-31) — Common Stock Payments: -2663000.00
BCAL cash_flow (quarterly, 2025-12-31) — Common Stock Payments: 272000.00
BCAL cash_flow (annual, 2025-12-31) — Deferred Income Tax: 11482000.00
BCAL cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 2711000.00
BCAL cash_flow (annual, 2025-12-31) — Deferred Tax: 11482000.00
BCAL cash_flow (quarterly, 2025-12-31) — Deferred Tax: 2711000.00
BCAL cash_flow (annual, 2025-12-31) — Depreciation: 1824000.00
BCAL cash_flow (quarterly, 2025-12-31) — Depreciation: 402000.00
BCAL cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 5615000.00
BCAL cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 1349000.00
BCAL income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 3791000.00
BCAL income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 947000.00
BCAL cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 5615000.00
BCAL cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 1349000.00
BCAL income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 3791000.00
BCAL income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 947000.00
BCAL income_statement (annual, 2025-12-31) — Diluted Average Shares: 32746110.00
BCAL income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 32787551.00
BCAL income_statement (annual, 2025-12-31) — Diluted EPS: 1.93
BCAL income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.50
BCAL income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 63058000.00
BCAL income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 16422000.00
BCAL cash_flow (annual, 2025-12-31) — End Cash Position: 399913000.00